Yaodong Li | Electrophysiology | Best Researcher Award

Prof. Yaodong Li | Electrophysiology | Best Researcher Award

Prof. Yaodong Li, Department of Pacing and Electrophysiology, the First Affiliated Hospital of Xinjiang Medical University, China

Prof. Yaodong Li is a leading expert in cardiac electrophysiology at the First Affiliated Hospital of Xinjiang Medical University, China. He holds a Doctor of Medicine in Cardiology from Xinjiang Medical University and serves as Professor and Chief Physician at the Cardiovascular Disease Center. Renowned for his work in pacing and atrial fibrillation, he has received numerous national and regional awards for scientific and clinical innovation. With several projects funded by the National Natural Science Foundation of China, Prof. Li is recognized as a “Research-oriented Talent” and continues to advance cardiovascular medicine through research, clinical excellence, and education.

AUTHOR PROFILE

Scopus Profile

🎓 EARLY ACADEMIC PURSUITS:

Prof. Yaodong Li embarked on his medical journey at Xinjiang Medical University, where he pursued a Doctor of Medicine in Cardiology from September 2008 to July 2012 in Urumqi, Xinjiang. His foundational years in this esteemed institution laid the groundwork for a career deeply rooted in cardiovascular research and clinical excellence. During his academic training, he quickly distinguished himself through rigorous study and early contributions to scientific research.

📚 PROFESSIONAL ENDEAVORS:

Since August 2018, Prof. Li has served as a Professor and Chief Physician at the Cardiovascular Disease Center of Xinjiang Medical University. His professional journey reflects an upward trajectory marked by commitment to patient care, cutting-edge electrophysiological techniques, and leadership in academic medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ELECTROPHYSIOLOGY:

Prof. Li’s core expertise lies in cardiac electrophysiology, pacing, and atrial fibrillation management. He has been actively involved in national and regional scientific research projects, showcasing a strong focus on innovative treatment modalities and clinical electrophysiological advancements. His research is widely respected for its clinical relevance and technical innovation.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s work has earned him numerous awards and honors, demonstrating his prominence within the national and regional cardiology communities:

  • 2008–2023: Multiple Scientific and Technological Progress Awards from Urumqi City and Xinjiang Autonomous Region

  • 2012: Awarded for Excellent Paper at the 10th National Academic Biannual Meeting of the Chinese Society of Electrophysiology and Pacing

  • 2013 & 2014: Second Prize at the Xinjiang Natural Science Awards (Ranked 2nd)

  • 2022: Recognized with the “Elite in Atrial Fibrillation Prevention and Treatment” Clinical Technology Innovation Honor

  • 2023: Swept honors at the 14th Pacing Summit Forum including:

    • First Prize for Excellent ICD Case

    • Second Prize for Leadless Excellent Case

    • Excellent Young Physician Award

🔎 ACADEMIC CITES AND RECOGNITION:

His studies have contributed significantly to Chinese cardiovascular literature, often cited in national medical conferences and publications. His rankings in award listings reflect not only quality research but also peer acknowledgment of his impact on clinical practice and knowledge dissemination.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Yaodong Li represents the future of electrophysiology in China—a visionary in device therapy, pacing technologies, and clinical research leadership. As a “Research-oriented Talent” honored by the Chinese Research Hospital Association in 2024, he is set to:

  • Inspire a new generation of electrophysiologists

  • Spearhead multicenter research projects on atrial fibrillation and ICD innovations

  • Promote global collaborations in cardiac rhythm management

🌍CONCLUSION:

Prof. Yaodong Li stands as a distinguished figure in the field of cardiac electrophysiology, blending clinical expertise with groundbreaking research and innovation. His dedication to advancing pacing techniques and atrial fibrillation treatment has earned him national recognition, prestigious awards, and significant research funding. As a mentor, physician, and scientist, he continues to shape the future of cardiovascular care in China and beyond. With a passion for excellence and a commitment to improving patient outcomes, Prof. Li remains a true pioneer and inspiration in the world of cardiology.

TOP NOTABLE PUBLICATIONS

Title: MAPK14/AIFM2 pathway regulates mitophagy-dependent apoptosis to improve atrial fibrillation
Authors: Wang, Lu; Sang, Wanyue; Jian, Yi; …; Tang, Baopeng; Li, Yaodong
Journal: Journal of Molecular and Cellular Cardiology
Year: 2025

Title: The impact of frailty on the prognosis of chronic heart failure patients treated with cardiac resynchronization therapy defibrillator implantation
Authors: Gao, Liang; Lyu, Huasheng; Tang, Baopeng; …; Zukela, Tuerhong; Lu, Yanmei
Journal: Zhonghua Nei Ke Za Zhi (Chinese Journal of Internal Medicine)
Year: 2025

Title: Effect of renal denervation on atrial neural and structural remodeling in rats with obesity-related atrial fibrillation and its mechanism
Authors: Jian, Yi; Sang, Wanyue; Wang, Lu; …; Zhang, Xing; Li, Yaodong
Journal: Chinese Journal of Pathophysiology
Year: 2024

Title: Safety and efficacy of cardioneuroablation for vagal bradycardia in a single arm prospective study
Authors: Han, Yafan; Shao, Mingliang; Yang, Hang; …; Tang, Baopeng; Li, Yaodong
Journal: Scientific Reports
Year: 2024

Title: A case of endocardial dissection caused by Micra implantation
Authors: Zhang, Jianghua; Shang, Shuai; Dong, Zhenyu; …; Xiaokereti, Jiasuoer; Tang, Baopeng
Journal: BMC Cardiovascular Disorders
Year: 2024

Title: Strategy Optimization for a Combined Procedure in Patients With Atrial Fibrillation: The COMBINATION Randomized Clinical Trial
Authors: Du, Xianfeng; Chu, Huimin; Yang, Bing; …; Yu, Xinzhi; Chen, Xiaomin
Journal: JAMA Network Open
Year: 2024

Title: CALCOCO2 prevents AngII-induced atrial remodeling by regulating the interaction between mitophagy and mitochondrial stress
Authors: Sang, Wanyue; Yan, Xiaoji; Wang, Lu; …; Tang, Baopeng; Li, Yaodong
Journal: International Immunopharmacology
Year: 2024

Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza | Hypertension | Best Research Article Award

Assist. Prof. Dr. Christina Antza, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Assist. Prof. Dr. Christina Antza is a specialist in Internal Medicine and Hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, Greece. She holds an M.D., a Ph.D. in blood pressure measurement methods, and an M.Sc. in Research Methodology. Dr. Antza has extensive experience in hypertension, metabolic syndrome, diabetes, and atherosclerosis. She has worked as a researcher, consultant, and medical educator in Greece and the UK. Recognized with multiple awards and fellowships, she actively contributes to international medical research and education, shaping advancements in cardiovascular and metabolic disease management.

AUTHOR PROFILE

Orcid Profile

🎓 EARLY ACADEMIC PURSUITS:

Dr. Christina Antza began her educational journey at the Fifth High-School of Drama (Junior High School) and Third High School of Drama (Senior High School). She then pursued her Medical Degree at Aristotle University of Thessaloniki, Greece (2007-2013), graduating with an impressive 8/10 grade.

Her passion for research and academia led her to further studies, including:

  • Ph.D. in Internal Medicine (2014-2019) – Focused on blood pressure measurement methods and their ability to predict early vascular aging. She earned a Grade A with Distinction under the supervision of Prof. V. Kotsis.
  • Master of Science in Research Methodology in Medicine and Health Science (2016-2018) – Achieved an outstanding 9/10 grade.
  • Research Fellowship (2019-2020) – Conducted clinical and research work in Diabetes Mellitus and Obesity at the University of Birmingham, UK.
  • Postdoctoral Research (2019-2022) – Specialized in Hypertension and Metabolic Syndrome at Aristotle University of Thessaloniki.
  • Internal Medicine Consultant Certification (2021) – Earned after passing rigorous written and oral examinations.

💼 PROFESSIONAL ENDEAVORS:

Dr. Antza has held various prestigious roles in internal medicine, focusing on hypertension, metabolic syndrome, and endocrinology:

  • Scientific Associate (2013-2014) – Engaged in research and clinical practice in hypertension at the 3rd Department of Internal Medicine, Aristotle University of Thessaloniki.
  • Medical Resident (2016-2021) – Trained at Papageorgiou General Hospital, Aristotle University of Thessaloniki.
  • Academic Fellowship in Hypertension & Metabolic Syndrome (2021-2022) – Focused on clinical practice, independent teaching, and research.
  • Internal Medicine Consultant (2021-2023) – Served at Papageorgiou General Hospital and Bioclinic, offering expertise in hypertension, diabetes, and emergency medicine.
  • Assistant Professor of Internal Medicine – Hypertension (2023-Present) – Currently educating future medical professionals and leading research at Aristotle University of Thessaloniki.

Additionally, she has participated as a Subinvestigator in Phase 2 & 3 Clinical Trials, contributing to advancements in hypertension and metabolic disorders.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Antza has extensively researched hypertension, metabolic syndrome, diabetes, lipid disorders, and vascular aging. Her work has focused on:

  • Blood Pressure Measurement Techniques (Home, Ambulatory, and Clinical).
  • Atherosclerosis and Cardiovascular Risk.
  • Metabolic Syndrome and Obesity-Related Disorders.
  • Diabetes and Endocrine Disorders.

She has been actively involved in research collaborations with leading medical institutions, including Queen Elizabeth Hospital, Birmingham, UK, where she served as an Honorary Observer (2019-2022) in the Endocrinology Department.

🏆 IMPACT AND INFLUENCE:

Dr. Antza’s work has been recognized with numerous awards and fellowships:

  • Young Fellow of the European Atherosclerosis Society (2019-Present).
  • Young Fellow of the European Hypertension Society (2023-Present).
  • Recipient of multiple Investigator Grants & Travel Awards from the European Society of Hypertension (ESH) and European Atherosclerosis Society (EAS).
  • 1st Place Oral Presentation Award – 8th Panhellenic Congress of the Hellenic Atherosclerosis Society (2019).
  • 2nd Clinical Research Award – 9th Panhellenic Congress of the Hellenic Atherosclerosis Society (2020).
  • Young Investigator Fellowship Award – 89th EAS Virtual Congress (2021).

📖 ACADEMIC CITATIONS & SCHOLARSHIPS:

Dr. Antza’s research has been widely cited in medical literature, influencing clinical guidelines in hypertension and metabolic diseases. Her scholarly excellence has earned her:

  • Ph.D. Scholarship from the Hellenic Society of Atherosclerosis (2014-2015).
  • Postdoctoral Research Scholarship from the State Scholarship Foundation (2019-2021).
  • Award from the Medical Sciences Deanery for Ph.D. Research (2020).

🌍 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Christina Antza is poised to make significant future contributions in the diagnosis and management of hypertension, metabolic syndrome, and cardiovascular diseases. Her expertise in clinical research, education, and innovative treatment strategies will continue to shape internal medicine and patient care.

Her future goals include:
✔ Expanding research on hypertension-related complications and vascular aging.
✔ Leading international collaborations in cardiovascular and metabolic diseases.
✔ Mentoring the next generation of medical professionals and researchers.
✔ Contributing to global guidelines on hypertension and cardiovascular risk management.

Her dedication to patient care, research, and teaching makes her an influential figure in modern internal medicine and hypertension research.

🌟CONCLUSION :

Assist. Prof. Dr. Christina Antza is a dedicated clinician, researcher, and educator in the fields of hypertension, metabolic syndrome, and internal medicine. With a strong academic foundation, international research collaborations, and numerous accolades, she continues to advance medical knowledge and improve patient care. Her contributions to medical education and research have made a lasting impact, inspiring future generations of physicians. As she progresses in her career, Dr. Antza remains committed to innovation, scientific discovery, and excellence in healthcare, shaping the future of cardiovascular and metabolic disease management. Her work stands as a testament to dedication and expertise.

TOP NOTABLE PUBLICATIONS

Clinic, Ambulatory and Home Blood Pressure Monitoring for Metabolic Syndrome: Time to Change the Definition?

Journal: Medicina

Year: 2025

The Microbial Perspective: A Systematic Literature Review on Hypertension and Gut Microbiota

Journal: Nutrients

Year: 2024

The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal: Nutrients

Year: 2024

Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry

Journal: Biomedicines

Year: 2024

The Modern Environment: The New Secondary Cause of Hypertension?

Journal: Medicina

Year: 2023

The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population

Journal: Medicina

Year: 2023